Procter & Gamble Hygiene
Market cap ₹22,109 Cr
- P/E
- 27.96
- Day range
- ₹6,737.00 – ₹6,842.00
- 52-week range
- ₹6,579.00 – ₹13,657.00
- Volume
- 5,380
- Open
- ₹6,800.50
- Prev close
- ₹6,825.00
Latest results · Q1 FY27(standalone)Revenue ₹891 Cr-4.9%Profit ₹126 Cr-34.3%Margin 14.2%YoY vs the same quarter last year
No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.
Research profile
Composite 51 / 100Factor percentiles
Derived metrics
- Earn. yield
- 3.6%
- Graham no.
- ₹1,126.84
- vs Graham
- -83.5%
- ROE ÷ P/B
- 3.9%
- 12-1 mom.
- -48.9%
- Return / vol
- -2.55
- Magic Formula
- #52
- FCF yield
- 3.9%
Appears in 15 scans
Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.
Peer comparison
All 44 in FMCG| Company | M-cap | P/E | P/B | ROE | ROCE | OPM | D/E | Sales YoY |
|---|---|---|---|---|---|---|---|---|
| Hindustan UnileverHINDUNILVR | ₹4.27 L Cr | 40.78 | 8.77 | 30.7% | 28.0% | 23.0% | 0.03 | +10.1% |
| ITCITC | ₹3.26 L Cr | 16.45 | 4.46 | 29.5% | 39.0% | 27.0% | 0.03 | -11.1% |
| Nestle IndiaNESTLEIND | ₹2.26 L Cr | 55.48 | 39.17 | 76.3% | 85.0% | 24.0% | 0.08 | +20.3% |
| Varun BeveragesVBL | ₹1.38 L Cr | 40.80 | 6.82 | 16.9% | 20.0% | 28.0% | 0.13 | +20.4% |
| Britannia IndustriesBRITANNIA | ₹1.10 L Cr | 42.36 | 21.41 | 53.6% | 56.0% | 17.0% | 0.27 | +8.2% |
| MaricoMARICO | ₹1.00 L Cr | 53.24 | 23.64 | 44.3% | 47.0% | 21.0% | 0.13 | +22.9% |
| Tata Consumer ProductsTATACONSUM | ₹92,685 Cr | 56.69 | 4.38 | 7.4% | 9.0% | 14.0% | 0.13 | +11.9% |
| Procter & Gamble HygienePGHH | ₹22,109 Cr | 27.96 | 29.42 | 114.9% | 157.0% | 19.0% | 0.00 | -4.9% |
| Sector median | ₹14,774 Cr | 32.32 | 5.64 | 18.0% | 19.0% | 16.5% | 0.13 | +11.9% |
Sector as classified in the tracked universe; medians use every tracked FMCG company, and P/E only profitable ones. Tinted figures beat the median.
Latest news
Updated 8d agoHeadlines about Procter & Gamble Hygiene from the last two weeks in the financial press. Stories belong to their publishers; Parasram India does not endorse them.
Key metrics
- P/E (TTM)
- 28.0
- EPS (TTM)
- ₹243.60
- Price / Book
- 29.36
- ROE (FY26)
- 114.9%
- ROCE (latest year)
- 157%
- Dividend yield
- 3.38%
Moving averages (NSE)
- 20-day
- ₹6,933.63
- Price below
- 50-day
- ₹7,503.14
- Price below
- 200-day
- ₹9,523.92
- Price below
Charts & trends
From company filings. Amounts in ₹ crore.
Revenue, profit & margin - quarterly
₹ crore; a loss shows red. Operating margin below, same periods.
- Revenue
- Net profit
Operating margin
Who owns the company
% of equity by quarter, latest Sept 2026
- Promoter
- DII
- Public
- FII
Cash flows
Where cash came from and went, by fiscal year (₹ crore)
- Operating
- Investing
- Financing
- Free cash flow
Return on equity
Net profit over shareholders' equity, by fiscal year
Equity vs debt
Shareholders' equity against borrowings (₹ crore); the ratio below, same years.
- Equity
- Debt
Debt to equity
Dividends per share
₹ by fiscal year of the ex-date; the latest year runs to date.
Financial statements
| Line item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,138 | 1,133 | 1,002 | 932 | 1,135 | 1,248 | 992 | 937 | 1,150 | 1,262 | 941 | 891 |
| Expenses | 853 | 824 | 745 | 813 | 845 | 877 | 782 | 671 | 865 | 860 | 723 | 721 |
| Operating Profit | 285 | 310 | 257 | 118 | 290 | 371 | 210 | 266 | 285 | 402 | 218 | 170 |
| OPM % | 25% | 27% | 26% | 13% | 26% | 30% | 21% | 28% | 25% | 32% | 23% | 19% |
| Other Income | 16 | 16 | 14 | 7 | 8 | 10 | 19 | 8 | 10 | 12 | 12 | 9 |
| Interest | 2 | 3 | 22 | 0 | 2 | 7 | 6 | 0 | 4 | 3 | 3 | 0 |
| Depreciation | 14 | 14 | 15 | 13 | 12 | 10 | 10 | 9 | 9 | 10 | 10 | 10 |
| Profit before tax | 284 | 309 | 234 | 112 | 285 | 364 | 213 | 265 | 282 | 402 | 218 | 170 |
| Tax % | 26% | 26% | 34% | 28% | 26% | 26% | 27% | 27% | 26% | 25% | 30% | 26% |
| Net Profit | 211 | 229 | 154 | 81 | 212 | 269 | 156 | 192 | 210 | 301 | 153 | 126 |
| EPS in Rs | ₹64.91 | ₹70.52 | ₹47.56 | ₹24.97 | ₹65.28 | ₹82.74 | ₹48.09 | ₹59.17 | ₹64.65 | ₹92.87 | ₹47.17 | ₹38.90 |
From company filings, updated 27 Oct 2026. Consolidated figures where the company reports them. Information only, not investment advice.
Working-capital cycle
+6 days since Jun 2021
-27 days since Jun 2021
-40 days since Jun 2021
+18 days since Jun 2021
+8 days since Jun 2021
Strengths, risks & growth
Procter & Gamble Hygiene and Health Care Limited is engaged in the manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. Its portfolio includes WHISPER – India’s leading Feminine Hygiene brand, and VICKS – India’s No. 1 Health Care brand and Old Spice.
Strengths
- Company has reduced debt.
- Company is almost debt free.
- Stock is providing a good dividend yield of 3.38%.
- Company has a good return on equity (ROE) track record: 3 Years ROE 89.3%
- Company has been maintaining a healthy dividend payout of 91.5%
Risks
- Stock is trading at 29.3 times its book value
- The company has delivered a poor sales growth of 7.40% over past five years.
Compounded Sales Growth
- 10 Years
- +6%
- 5 Years
- +7%
- 3 Years
- +3%
- TTM
- -2%
Compounded Profit Growth
- 10 Years
- +9%
- 5 Years
- +14%
- 3 Years
- +14%
- TTM
- -5%
Stock Price CAGR
- 10 Years
- 0%
- 5 Years
- -13%
- 3 Years
- -26%
- 1 Year
- -49%
Return on Equity
- 10 Years
- +60%
- 5 Years
- +83%
- 3 Years
- +89%
- Last Year
- +115%
Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.
Shareholding pattern
| Holder | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 | Change |
|---|---|---|---|---|---|
| Promoter | 70.64% | 70.64% | 70.64% | 70.64% | 0.00 pp |
| FII | 1.06% | 0.97% | 0.98% | 0.61% | -0.37 pp |
| DII | 16.03% | 15.96% | 15.58% | 15.03% | -0.55 pp |
| Public | 12.25% | 12.43% | 12.79% | 13.70% | +0.91 pp |
Filed with NSE for Sept 2026: promoters 70.64%, public 29.36% · XBRL filing
Analysts & fund holdings
Who holds the shares, quarter by quarter
Mutual funds 7.41% (-0.59 pp)- Promoters70.6%
- Foreign institutions0.6%
- Mutual funds7.4%
- Insurance7.6%
- Other domestic institutions0.0%
- Retail10.3%
- Others3.4%
| Fund | % of company | % of fund | 3-month change |
|---|---|---|---|
| SBI Focused Fund | 2.63% | 1.22% | -0.51 pp |
| ICICI Pru Large Cap Fund | 1.36% | 0.40% | -0.13 pp |
| SBI Aggressive Hybrid Fund | 1.26% | 0.34% | -0.12 pp |
| SBI Midcap Fund | 0.91% | 0.91% | -0.26 pp |
| UTI MNC Fund | 0.21% | 1.77% | -0.51 pp |
Scorecard
- Performance
- Low
- Valuation
- High
- Growth
- Low
- Profitability
- High
- Entry point
- Good
- Red flags
- Low
Analyst coverage, holdings and scorecard from market data; not a recommendation by Parasram India.
Risk & trend
From 275 daily sessions to 23 Oct 2026.
Risk
- Volatility (1Y)
- 20.4%
- Downside volatility
- 21.3%
- Worst 5% of days
- 2.3%
- Average of that tail
- 3.2%
- Max drawdown (1Y)
- 53.8%
- Below its peak
- 52.5%
Against the market
- Beta vs Nifty 50
- 0.37
- Correlation
- 0.24
- Relative strength (3M)
- -18.7%
- ATR (14)
- 2.5%
Return
- Return 1M
- -6.3%
- Return 3M
- -24.0%
- Return 6M
- -34.6%
- Return 1Y
- -52.1%
- vs 200-day average
- -28.3%
Momentum
- RSI (14)
- 35.0
- MACD histogram
- 31.84
- Stochastic %K
- 32.6
- ADX (14)
- 35.2
- +DI / −DI
- 14.7 / 30.4
- Money flow index
- 64.3
Participation
- Delivery (20d avg)
- 52.6%
- vs its 60-day baseline
- -3.1 pts
- Volume vs 20-day
- +0.0σ
- Close vs day's VWAP
- +0.9%
- 52-week position
- 2 / 100
These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.
Financial quality
From consolidated statements to 31 Mar 2026.
No F-Score: it needs two reporting periods a year apart that carry both an income statement and a balance sheet, and this company's filings do not yet line up that way. The ratios below need only the one period and are unaffected.
- Free cash flow
- ₹875 Cr
- FCF yield
- 3.9%
- Net debt
- -₹556 Cr
- Net debt / equity
- -0.74
- EV / sales
- 5.09
Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.
Corporate actions
- dividend₹60.00
Dividend - Rs 60 Per Share
1 Sept 2026ex-date - dividend₹170.00
Interim Dividend - Rs 170 Per Share/ Special Dividend - Rs 25 Per Share
5 Feb 2026ex-date - dividend₹65.00
Dividend - Rs 65 Per Share
28 Aug 2025ex-date - dividend₹110.00
Interim Dividend - Rs 110 Per Share
20 Feb 2025ex-date - dividend₹95.00
Annual General Meeting/Dividend - Rs 95 Per Share
19 Nov 2024ex-date - dividend₹100.00
Interim Dividend - Rs 100 Per Share/ Special Dividend - Rs 60 Per Share
9 Feb 2024ex-date - dividend₹105.00
Annual General Meeting/Dividend - Rs 105 Per Share
17 Nov 2023ex-date - dividend₹80.00
Interim Dividend - Rs 80 Per Share
8 Feb 2023ex-date - dividend₹65.00
Annual General Meeting/Dividend - Rs 65 Per Share
4 Nov 2022ex-date - dividend₹95.00
Interim Dividend - Rs 95 Per Share
8 Feb 2022ex-date - dividend₹80.00
Annual General Meeting/Dividend - Rs 80 Per Share
9 Nov 2021ex-date - dividend₹150.00
Special Dividend - Rs 150 Per Share
11 May 2021ex-date - dividend₹85.00
Interim Dividend - Rs 85 Per Share
10 Feb 2021ex-date - dividend₹105.00
Annual General Meeting/Dividend - Rs 105 Per Share
13 Nov 2020ex-date - dividend₹48.00
Dividend Rs 48 Per Eq Sh
19 Nov 2019ex-date - dividend₹40.00
Interim Dividend - Rs 40 Per Share
15 Feb 2019ex-date - dividend₹40.00
Annual General Meeting/Dividend Rs 40 Per Share
20 Nov 2018ex-date - dividend₹27.00
Dividend - Rs 27/- Per Share
7 Nov 2017ex-date - dividend₹362.00
Special Interim Dividend Rs 362/- Per Share
17 May 2017ex-date - dividend₹36.00
Dividend Rs 36/- Per Share
24 Nov 2016ex-date - dividend₹30.25
Dividend - Rs 30.25/- Per Share
19 Oct 2015ex-date
Company announcements
The Company has submitted Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026
Procter & Gamble Hygiene And Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Unaudited ....
The Company has informed the Exchange regarding closure of trading window for the quarter ended September 30, 2026
The Company has informed the Exchange regarding appointment of Ms. Flavia Machado as Company Secretary and Compliance Officer of the Company effective September 29, 2026
The Company has submitted clarification to the Exchange on account of Material Price Movement
The Company has informed the Exchange regarding the update on Special Window for Transfer and Dematerialization of Physical Securities
The Company has informed the Exchange regarding appointment of Ms. Srividya Srinivasan as the Whole-time Director of the Company effective July 1, 2026.
The Company has informed the Exchange regarding Scrutinizer's Report for the AGM held on September 8, 2026
The Company has informed the Exchange regarding proceedings of 62nd AGM of the Company held on September 8, 2026
Annual Report of the Company for the Financial Year ended March 31, 2026
Business Responsibility and Sustainability Report for the Financial Year ended March 31, 2026
Notice of Annual General Meeting of the Company
The Company has informed the Exchange regarding revised Record date for the purpose of AGM and Dividend, if approved
The Company has informed the Exchange regarding revised date of Annual General Meeting
Company has informed the exchange about the unaudited financial results for the quarter ended June 30, 2026
Filed with BSE (scrip 500459); the last 45 days. Documents open at bseindia.com.
Documents
Annual reports
Earnings calls
- Jun 2026TranscriptSlidesRecording
- Jun 2025TranscriptSlidesRecording
- Sep 2024TranscriptSlides
- Sep 2023TranscriptSlides
- Mar 2019Slides
Documents open at BSE or the rating agency that issued them.
Sourced from the company's NSE XBRL filing dated 29 Jul 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.
Procter & Gamble Hygiene: common questions
Answered from the figures on this page.
